Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular signal-regulated kinases (ERKs) are a family of serine/threonine protein kinases that play a central role in the regulation of diverse cellular processes, including proliferation, differentiation, survival, migration, and gene expression. ERKs are key components of the mitogen-activated protein kinase (MAPK) signaling pathway and are widely expressed in mammalian cells. Disruption or hyperactivation of the Ras-Raf-MEK-ERK pathway is common in many cancers. Targeted inhibition has become an important anti-cancer strategy; however, only certain inhibitors like those against mutant B-Raf have shown significant clinical efficacy so far. Other diseases associated with aberrant regulation include chronic inflammation disorders such as arthritis or osteoporosis.
Inhibition of ERK phosphorylation and activation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular signal-regulated kinases (ERK).